Thus, array-based karyotyping revealed MDS and related myeloid neoplasms with a normal karyotype to have one or more genomic abnormalities, including deletions of TET2 and RUNX1 genes (40%) [26,27,29]. Here, RUNX1 is linked to myelodysplastic syndrome.